InsightPFA Trial of the LotosPFA Catheter
NCT06014996 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 292
Last updated 2025-08-17
Summary
This trial aims to determine whether the InsightPFA for PVI is as effective and safe as standard RFA in the treatment of symptomatic paroxysmal AF.
Conditions
- Arrhythmias, Cardiac
- Paroxysmal Atrial Fibrillation
Interventions
- DEVICE
-
Pulsed Field Ablation (PFA) Therapy
In the test group, subjects will undertake PVI using the PFA system including a nanosecond-scale pulsed field generator (InRythm, Insight Lifetech, Shenzhen, China), a lotos catheter that is expandable over the wire (LotosPFA, Insight Lifetech), and a customized 12-French steerable sheath (InBridge, Insight Lifetech).
- DEVICE
-
Radiofrequency Ablation(RAF)Therapy
In the control group, subjects will undergo PVI using an RFA system including CARTO VISITAG Module and the THERMOCOOL SMARTTOUCH Catheter (Biosense Webster Inc., Diamond Bar, CA, USA). PVI was performed with AI values of 400-450 in the anterior, 300-350 at the posterior wall of the LA.
Sponsors & Collaborators
-
Insight Lifetech Co., Ltd.
collaborator INDUSTRY -
Guangdong Provincial People's Hospital
collaborator OTHER -
Beijing Anzhen Hospital
collaborator OTHER -
Sir Run Run Shaw Hospital
collaborator OTHER -
Shanghai Zhongshan Hospital
collaborator OTHER -
The Affiliated People's Hospital of Ningbo University
collaborator OTHER_GOV -
The First Affiliated Hospital of Dalian Medical University
collaborator OTHER -
Nanfang Hospital, Southern Medical University
collaborator OTHER -
Xiamen Cardiovascular Hospital, Xiamen University
collaborator OTHER -
Yan'an Affiliated Hospital of Kunming Medical University
collaborator OTHER -
Weifang People's Hospital
collaborator OTHER -
Insight Medtech Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-04
- Primary Completion
- 2025-06-09
- Completion
- 2025-07-03
Countries
- China
Study Locations
More Related Trials
-
CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
NCT03056222 ·Status: COMPLETED ·Phase: NA
-
Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation
NCT06791629 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PFLotus With the DePolar Mapping System in Patients With Persistent Atrial Fibrillation
NCT07321002 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pulsed-Field-Ablation to Treat Atrial fiBRillation With a novEl multimodalIty Generator
NCT06156644 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
3D-Guided Pulsed Field Ablation for Paroxysmal AF
NCT07023237 ·Status: NOT_YET_RECRUITING
-
LS-PersAFone: Pulsed Field Ablation for Long-Standing Persistent Atrial Fibrillation
NCT06128174 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)
NCT05114954 ·Status: COMPLETED ·Phase: NA
-
FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT02703454 ·Status: TERMINATED ·Phase: NA
-
Comparison of Two Pulmonary Vein Ablation Techniques for Persistent AF
NCT03295422 ·Status: UNKNOWN ·Phase: NA
-
FIRE AND ICE: Comparative Study of Two Ablation Procedures in Patients With Atrial Fibrillation
NCT01490814 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation
NCT04497376 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study on the Use of a Domestically Produced Three-dimensional Cardiac Electrophysiological Mapping System Combined With Pressure Monitoring Technology and Star Mapping Technology for the Treatment of Paroxysmal Atrial Fibrillation.
NCT07039032 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial Fibrillation
NCT06557876 ·Status: RECRUITING ·Phase: NA
-
Ablation of the Pulmonary Veins for Paroxysmal Afib
NCT00744874 ·Status: COMPLETED ·Phase: PHASE4
-
Inflammatory Response Following " Pulsed Field Ablation " vs. Radiofrequency Ablation-2
NCT06160076 ·Status: COMPLETED
-
The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
NCT04612244 ·Status: COMPLETED ·Phase: NA
-
Safety-and-effectiveness Clinical Evaluation of Nanosecond-pulse Ablation for Atrial Fibrillation
NCT06039722 ·Status: COMPLETED ·Phase: NA
-
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT06455098 ·Status: RECRUITING ·Phase: NA
-
Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation
NCT05144503 ·Status: RECRUITING ·Phase: NA
-
NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
NCT07018596 ·Status: RECRUITING ·Phase: NA
-
A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia
NCT05820035 ·Status: COMPLETED ·Phase: NA
-
Personalized Persistent Atrial Fibrillation Ablation: The PeAF-by-LAWT Trial
NCT05396534 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
NCT01687166 ·Status: COMPLETED ·Phase: NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
NCT06891456 ·Status: RECRUITING ·Phase: NA
-
Application-Based Integrated Care in Patients After Pulse Field Ablation
NCT07119528 ·Status: RECRUITING ·Phase: NA